Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2.

Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2.

Item
http://www.wikidata.org/entity/Q33636979
Novel cancer chemotherapy hits by molecular topology: dual Akt and Beta-catenin inhibitorsDecreased calpain 6 expression is associated with tumorigenesis and poor prognosis in HNSCC.Ubiquitin-proteasomal degradation of antiapoptotic survivin facilitates induction of apoptosis in prostate cancer cells by pristimerin.Inhibition of hTERT/telomerase contributes to the antitumor activity of pristimerin in pancreatic ductal adenocarcinoma cells.Mevalonate-derived quinonemethide triterpenoid from in vitro roots of Peritassa laevigata and their localization in root tissue by MALDI imaging.Xanthohumol-Mediated Suppression of Notch1 Signaling Is Associated with Antitumor Activity in Human Pancreatic Cancer Cells.Betulinic acid enhances TGF-β signaling by altering TGF-β receptors partitioning between lipid-raft/caveolae and non-caveolae membrane microdomains in mink lung epithelial cells.Pristimerin overcomes adriamycin resistance in breast cancer cells through suppressing Akt signaling.Compounds From Celastraceae Targeting Cancer Pathways and Their Potential Application in Head and Neck Squamous Cell Carcinoma: A Review.Effects of Glycyrrhizic Acid on the Pharmacokinetics of Pristimerin in Rats and its Potential Mechanism.Pristimerin as a Novel Hepatoprotective Agent Against Experimental Autoimmune Hepatitis.
P2860

Pristimerin, a quinonemethide triterpenoid, induces apoptosis in pancreatic cancer cells through the inhibition of pro-survival Akt/NF-κB/mTOR signaling proteins and anti-apoptotic Bcl-2.

Item
http://www.wikidata.org/entity/Q33636979
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@ast
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@en
type
label
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@ast
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@en
prefLabel
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@ast
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@en
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Pristimerin, a quinonemethide ...... eins and anti-apoptotic Bcl-2.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932